Thursday, December 4, 2008

MIT Holding, Inc.: Independent certification and validation of ProVectorTM Completed by Georgia Southern University

(BUSINESS WIRE) - The Georgia Southern University Research and Service Foundation located in Statesboro, GA, advised MIT on November 27, 2008 it had successfully completed its independent Validation and Certification of ProVectorTM Models under contract by MIT, Holding Inc.; portions of the study available on-line at

MIT can now offer for public use the first of the new line of ProVectorTM products developed by Dr. Tom Kollars from MEVLABS, Inc. and Pro Vector, LLC and licensed to MIT. ProVectorTM Bt (patent pending) is an economical and environmentally safe device for killing adult mosquitoes. The parts include a plastic flower with colors, chemical attractants and a refill containing Bacillus thuringiensis israelensis (Bt) biopesticide. One refill lasts from three to six months depending on the size of the mosquito population.

ProVectorTM Bt is unique because it is the first commercially available device to imitate a flower to which adult mosquitoes come to feed on Bacillus thuringiensis israelensis (Bt) pesticide. It was designed with the philosophy of keeping “Green” and made of virtually indestructible plastic which reduces waste and it only allows mosquitoes to feed on it, eliminating the spread of pesticides into the environment. The device includes a flower with color, chemical attractants, and a refill containing Bacillus thuringiensis israelensis (Bt) biopesticide. One refill will last from three to six months depending on the size of the mosquito population.

The active biopesticide Bt, is short for Bacillus thuringiensis, is a bacteria that has been studied by the US Environmental Protection Agency (EPA) and found Bt safe enough to be exempt from food residue tolerances, groundwater restrictions, species labeling and special review requirements. Bt has historically been used to treat water sources in order to kill mosquito larvae as they filter in water. However, adult mosquitoes do not live in water and have different feeding habits than larvae. In addition to blood, most female mosquitoes feed on sugar sources for energy and all male mosquitoes use sugar sources. The ProVectorTM imitates the look and taste of flowers in order to trick the adult mosquitoes into eating Bt. Dr. Kollars and his staff have had astonishing results with their ProVectorTM Bt formulation, having a kill rate of over 80% in 24 hours and 100% within a week in the laboratory.

ProVectorTM Bt seeks to achieve low cost and safety by using Bt in a contained manner without spreading it to the environment. MIT Holding is pleased to team with MEVLABS, Inc. and ProVector, LLC to provide the ProVectorTM Bt as another tool in the arsenal of public health officials and pest management professionals in their fight to battle mosquitoes and save lives.


MIT through its wholly owned subsidiaries, based in Savannah, Georgia, provides medical services to Hospitals, Clinics, Doctor’s offices and their Patients. Medical Infusion Technologies is a Pharmacy based infusion business. The licensed pharmacy can dispense infusible and non-infusible prescription pharmaceuticals to treat a wide range of chronic and acute health conditions. The home medical equipment division carries a wide variety of durable medical equipment and supplies for purchase or lease. The division maintains inventory and can rapidly obtain a wide variety of home medical equipment products to match almost any request. The Physician based Ambulatory Care Center provides eight on site intravenous suites for patients with a wide range of IV Therapy needs.

Forward-Looking Statements

Some of the information contained in this release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities and Exchange Act of 1934 the "Exchange Act"), which mean that they relate to events or transactions that have not yet occurred, our expectations or estimates for our future operations, our growth strategies or business plans or other facts that have not yet occurred. These statements can be identified by the use of forward-looking terminology such as "might," "may," "could," "expect," "anticipate," "estimate," "likely," "intend," "believe," or "continue" or the negative thereof or other variations thereon or comparable terminology. For an explanation of some of the risks and uncertainties facing MIT HOLDING and its investors, please see our most recent prospectus on file with the Securities Exchange Commission. The risk factors contained therein should be considered by prospective investors for their potential impact on forward-looking statements included in this release. These important factors, among others that might not be listed, may cause actual results to differ materially and adversely from the results expressed or implied by the forward-looking statements. We caution investors that such discussions of important risks and uncertainties are not exclusive, and our business may be subject to other risks and uncertainties, which are not detailed there.

Investors are cautioned not to place undue reliance on our forward-looking statements. We make forward-looking statements as of the date of this release, and we assume no obligation to update the forward-looking statements after the date hereof whether as a result of new information or events, changed circumstances, or otherwise, except as required by law.

Georgia Front Page
Fayette Front Page

News to Use in Fayetteville, Atlanta, Savannah, Statesboro and all of Georgia

No comments: